1. Home
  2. CVV vs MIRA Comparison

CVV vs MIRA Comparison

Compare CVV & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVV
  • MIRA
  • Stock Information
  • Founded
  • CVV 1982
  • MIRA 2020
  • Country
  • CVV United States
  • MIRA United States
  • Employees
  • CVV N/A
  • MIRA N/A
  • Industry
  • CVV Industrial Machinery/Components
  • MIRA Biotechnology: Pharmaceutical Preparations
  • Sector
  • CVV Technology
  • MIRA Health Care
  • Exchange
  • CVV Nasdaq
  • MIRA Nasdaq
  • Market Cap
  • CVV N/A
  • MIRA 20.5M
  • IPO Year
  • CVV N/A
  • MIRA 2023
  • Fundamental
  • Price
  • CVV $3.11
  • MIRA $1.04
  • Analyst Decision
  • CVV
  • MIRA Strong Buy
  • Analyst Count
  • CVV 0
  • MIRA 2
  • Target Price
  • CVV N/A
  • MIRA $14.00
  • AVG Volume (30 Days)
  • CVV 17.2K
  • MIRA 2.9M
  • Earning Date
  • CVV 05-12-2025
  • MIRA 05-12-2025
  • Dividend Yield
  • CVV N/A
  • MIRA N/A
  • EPS Growth
  • CVV N/A
  • MIRA N/A
  • EPS
  • CVV N/A
  • MIRA N/A
  • Revenue
  • CVV $26,876,000.00
  • MIRA N/A
  • Revenue This Year
  • CVV N/A
  • MIRA N/A
  • Revenue Next Year
  • CVV N/A
  • MIRA N/A
  • P/E Ratio
  • CVV N/A
  • MIRA N/A
  • Revenue Growth
  • CVV 11.48
  • MIRA N/A
  • 52 Week Low
  • CVV $2.53
  • MIRA $0.51
  • 52 Week High
  • CVV $5.25
  • MIRA $5.01
  • Technical
  • Relative Strength Index (RSI)
  • CVV 54.18
  • MIRA 55.23
  • Support Level
  • CVV $2.91
  • MIRA $0.84
  • Resistance Level
  • CVV $3.15
  • MIRA $1.33
  • Average True Range (ATR)
  • CVV 0.16
  • MIRA 0.10
  • MACD
  • CVV 0.02
  • MIRA 0.02
  • Stochastic Oscillator
  • CVV 86.57
  • MIRA 51.67

About MIRA MIRA Pharmaceuticals Inc.

Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

Share on Social Networks: